en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu

Recognizing National Colorectal Cancer Awareness Month in March

In 2000, March was officially designated as National Colon Cancer Awareness Month.  Since then, it has grown to be a rallying point for the colon cancer community where thousands of patients, survivors, caregivers and advocates throughout the country join together to spread colon cancer awareness by wearing blue (on the first Friday of March), holding fundraising and education events, talking to friends and family about screenings and much more.  

According to the American Cancer Society, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States.  The American Cancer Society’s estimates 95,270 new cases of colon cancer will be diagnosed in the U.S. in 2016. 

Colorectal cancer, or colon cancer, occurs in the colon or rectum.  Most colorectal cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids).  Most colon cancers develop first as polyps, which are abnormal growths inside the colon or rectum that may later become cancerous.  

Since colorectal cancer often begins as polyps, it is important to find and remove them in order to help prevent colorectal cancer.  That is where screening comes in.  Expert medical groups, including the U.S. Preventive Services Task Force, strongly recommend screening for colorectal cancer.  Although minor details of the recommendations may vary, these groups generally recommend that people at average risk of colorectal cancer get screened at regular intervals with high-sensitivity fecal occult blood tests (FOBT), sigmoidoscopy, or a colonoscopy beginning at age 50.  People at increased risk because of a family history of colorectal cancer, polyps, or because they have inflammatory bowel disease, may be advised to start screening before age 50 or have more frequent screening. 

At the Cancer Treatment Center at Hazleton, we treat colon cancer painlessly and noninvasively with external beam radiation therapy (EBRT).  EBRT is an effective treatment for colon cancer, working within cancer cells to limit their ability to multiply.  During treatment, high-energy X-rays are delivered to the cancer with a linear accelerator (LINAC).  The treatment process is painless, safe and treatments take about 10 to 15 minutes.  Side effects are usually minimal, and most patients return to routine activities immediately after each treatment.  

For more information about how colorectal cancer is treated at the Cancer Treatment Center at Hazelton, please click here